278 related articles for article (PubMed ID: 30053503)
1. Targeting Bcl-2-IP
Distelhorst CW
Biochim Biophys Acta Mol Cell Res; 2018 Nov; 1865(11 Pt B):1795-1804. PubMed ID: 30053503
[TBL] [Abstract][Full Text] [Related]
2. The selective BH4-domain biology of Bcl-2-family members: IP3Rs and beyond.
Monaco G; Vervliet T; Akl H; Bultynck G
Cell Mol Life Sci; 2013 Apr; 70(7):1171-83. PubMed ID: 22955373
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2 and IP
Ivanova H; Wagner LE; Tanimura A; Vandermarliere E; Luyten T; Welkenhuyzen K; Alzayady KJ; Wang L; Hamada K; Mikoshiba K; De Smedt H; Martens L; Yule DI; Parys JB; Bultynck G
Cell Mol Life Sci; 2019 Oct; 76(19):3843-3859. PubMed ID: 30989245
[TBL] [Abstract][Full Text] [Related]
4. Bcl-2 regulation of the inositol 1,4,5-trisphosphate receptor and calcium signaling in normal and malignant lymphocytes: potential new target for cancer treatment.
Greenberg EF; Lavik AR; Distelhorst CW
Biochim Biophys Acta; 2014 Oct; 1843(10):2205-10. PubMed ID: 24642270
[TBL] [Abstract][Full Text] [Related]
5. Selective regulation of IP3-receptor-mediated Ca2+ signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl.
Monaco G; Decrock E; Akl H; Ponsaerts R; Vervliet T; Luyten T; De Maeyer M; Missiaen L; Distelhorst CW; De Smedt H; Parys JB; Leybaert L; Bultynck G
Cell Death Differ; 2012 Feb; 19(2):295-309. PubMed ID: 21818117
[TBL] [Abstract][Full Text] [Related]
6. Proapoptotic BAX and BAK regulate the type 1 inositol trisphosphate receptor and calcium leak from the endoplasmic reticulum.
Oakes SA; Scorrano L; Opferman JT; Bassik MC; Nishino M; Pozzan T; Korsmeyer SJ
Proc Natl Acad Sci U S A; 2005 Jan; 102(1):105-10. PubMed ID: 15613488
[TBL] [Abstract][Full Text] [Related]
7. Biological Regulatory Network (BRN) Analysis and Molecular Docking Simulations to Probe the Modulation of IP
Ismatullah H; Jabeen I; Saeed MT
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33383780
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in canonical versus non-canonical Ca
Cauwelier C; de Ridder I; Bultynck G
Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119713. PubMed ID: 38521468
[TBL] [Abstract][Full Text] [Related]
9. Ryanodine receptors are targeted by anti-apoptotic Bcl-XL involving its BH4 domain and Lys87 from its BH3 domain.
Vervliet T; Lemmens I; Vandermarliere E; Decrock E; Ivanova H; Monaco G; Sorrentino V; Nadif Kasri N; Missiaen L; Martens L; De Smedt H; Leybaert L; Parys JB; Tavernier J; Bultynck G
Sci Rep; 2015 Apr; 5():9641. PubMed ID: 25872771
[TBL] [Abstract][Full Text] [Related]
10. Host IP
Perry JL; Scribano FJ; Gebert JT; Engevik KA; Ellis JM; Hyser JM
mBio; 2024 Jan; 15(1):e0214523. PubMed ID: 38112482
[TBL] [Abstract][Full Text] [Related]
11. Creating a New Cancer Therapeutic Agent by Targeting the Interaction between Bcl-2 and IP
Distelhorst CW; Bootman MD
Cold Spring Harb Perspect Biol; 2019 Sep; 11(9):. PubMed ID: 31110129
[TBL] [Abstract][Full Text] [Related]
12. BDA-366, a putative Bcl-2 BH4 domain antagonist, induces apoptosis independently of Bcl-2 in a variety of cancer cell models.
Vervloessem T; Sasi BK; Xerxa E; Karamanou S; Kale J; La Rovere RM; Chakraborty S; Sneyers F; Vogler M; Economou A; Laurenti L; Andrews DW; Efremov DG; Bultynck G
Cell Death Dis; 2020 Sep; 11(9):769. PubMed ID: 32943617
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2-Protein Family as Modulators of IP
Ivanova H; Vervliet T; Monaco G; Terry LE; Rosa N; Baker MR; Parys JB; Serysheva II; Yule DI; Bultynck G
Cold Spring Harb Perspect Biol; 2020 Apr; 12(4):. PubMed ID: 31501195
[TBL] [Abstract][Full Text] [Related]
14. Cancer cell death strategies by targeting Bcl-2's BH4 domain.
de Ridder I; Kerkhofs M; Veettil SP; Dehaen W; Bultynck G
Biochim Biophys Acta Mol Cell Res; 2021 Apr; 1868(5):118983. PubMed ID: 33549704
[TBL] [Abstract][Full Text] [Related]
15. BIRD-2, a BH4-domain-targeting peptide of Bcl-2, provokes Bax/Bak-independent cell death in B-cell cancers through mitochondrial Ca
Kerkhofs M; La Rovere R; Welkenhuysen K; Janssens A; Vandenberghe P; Madesh M; Parys JB; Bultynck G
Cell Calcium; 2021 Mar; 94():102333. PubMed ID: 33450506
[TBL] [Abstract][Full Text] [Related]
16. New Insights in the IP
Parys JB; Vervliet T
Adv Exp Med Biol; 2020; 1131():243-270. PubMed ID: 31646513
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological effects of berberine on models of ulcerative colitis: A meta-analysis and systematic review of animal studies.
Hu S; Wei P; Li W; Liu Q; Chen S; Hu C; Guo X; Ma X; Zeng J; Zhang Y
Front Pharmacol; 2022; 13():937029. PubMed ID: 36147325
[TBL] [Abstract][Full Text] [Related]
18. Allosteric cross-talk between the hydrophobic cleft and the BH4 domain of Bcl-2 in control of inositol 1,4,5-trisphosphate receptor activity.
Shapovalov G; Ritaine A; Essonghe NC; de Ridder I; Ivanova H; Karamanou S; Economou A; Bultynck G; Skryma R; Prevarskaya N
Explor Target Antitumor Ther; 2022; 3(3):375-391. PubMed ID: 36045908
[TBL] [Abstract][Full Text] [Related]
19. Calcium signaling in hepatitis B virus infection and its potential as a therapeutic target.
Kong F; Zhang F; Liu X; Qin S; Yang X; Kong D; Pan X; You H; Zheng K; Tang R
Cell Commun Signal; 2021 Aug; 19(1):82. PubMed ID: 34362380
[TBL] [Abstract][Full Text] [Related]
20. Bok binds to a largely disordered loop in the coupling domain of type 1 inositol 1,4,5-trisphosphate receptor.
Szczesniak LM; Bonzerato CG; Schulman JJ; Bah A; Wojcikiewicz RJH
Biochem Biophys Res Commun; 2021 May; 553():180-186. PubMed ID: 33773141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
